- Corporate Officers - B
- Bitterman Kevin
Insider Trading History of Bitterman Kevin
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Bitterman Kevin since 2016.
This trader's CIK number is 1591747.
At the time of last reporting, Bitterman Kevin was the Officer of Disc Medicine, Inc.. (stock ticker symbol IRON).
Also see all insider trading activities at Disc Medicine, Inc..
Note that in the past
Bitterman Kevin also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Disc Medicine, Inc. (IRON) by Bitterman Kevin
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | IRON | 0 | $0 | 86,882 | $5,305,265 | 0 | $0 |
| 2024 | IRON | 222,223 | $8,000,028 | 148,657 | $10,136,664 | 0 | $0 |
| 2023 | IRON | 0 | $0 | 148,995 | $8,520,499 | 0 | $0 |
Yearly summary of insider trading at Akero Therapeutics, Inc. (AKRO) by Bitterman Kevin
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | AKRO | 0 | $0 | 17,489 | $459,610 | 0 | $0 |
| 2020 | AKRO | 0 | $0 | 13,000 | $376,090 | 0 | $0 |
| 2019 | AKRO | 270,000 | $4,320,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Editas Medicine, Inc. (EDIT) by Bitterman Kevin
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | EDIT | 0 | $0 | 1,000,000 | $17,000,000 | 0 | $0 |
| 2016 | EDIT | 0 | $0 | 859,029 | $14,207,011 | 0 | $0 |
Insider trading activities at 3 companies by Bitterman Kevin:
1. Disc Medicine, Inc. (IRON)
2. Akero Therapeutics, Inc. (AKRO)
3. Editas Medicine, Inc. (EDIT)
Table 1. Insider trading of Disc Medicine, Inc. (IRON) by Bitterman Kevin
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-08-22 | IRON | Sale | 2,287 | 61.03 | 139,575 |
| 2025-08-13 | IRON | Sale | 24,962 | 61.15 | 1,526,426 |
| 2025-08-14 | IRON | Sale | 7,212 | 60.99 | 439,859 |
| 2025-08-05 | IRON | Sale | 395 | 60.95 | 24,075 |
| 2025-07-30 | IRON | Sale | 8,492 | 61.04 | 518,351 |
| 2025-07-23 | IRON | Sale | 29,837 | 60.97 | 1,819,161 |
| 2025-07-24 | IRON | Sale | 13,033 | 61.17 | 797,228 |
| 2025-07-18 | IRON | Sale | 664 | 61.13 | 40,590 |
| 2024-06-17 | IRON | Buy | 222,223 | 36.00 | 8,000,028 |
| 2024-03-05 | IRON | Sale | 26,157 | 73.50 | 1,922,539 |
| 2024-01-23 | IRON | Sale | 102,500 | 67.65 | 6,934,125 |
| 2024-01-10 | IRON | Sale | 20,000 | 64.00 | 1,280,000 |
| 2023-12-14 | IRON | Sale | 20,549 | 59.01 | 1,212,493 |
| 2023-12-12 | IRON | Sale | 51,967 | 62.98 | 3,272,673 |
| 2023-12-13 | IRON | Sale | 3,548 | 60.24 | 213,749 |
| 2023-08-15 | IRON | Sale | 72,931 | 52.40 | 3,821,584 |
Table 2. Insider trading of Akero Therapeutics, Inc. (AKRO) by Bitterman Kevin
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-06-01 | AKRO | Sale | 17,489 | 26.28 | 459,610 |
| 2020-10-09 | AKRO | Sale | 13,000 | 28.93 | 376,090 |
| 2019-06-24 | AKRO | Buy | 270,000 | 16.00 | 4,320,000 |
Table 3. Insider trading of Editas Medicine, Inc. (EDIT) by Bitterman Kevin
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-05-22 | EDIT | Sale | 1,000,000 | 17.00 | 17,000,000 |
| 2016-12-07 | EDIT | Sale | 75,000 | 15.82 | 1,186,500 |
| 2016-12-06 | EDIT | Sale | 50,000 | 15.87 | 793,500 |
| 2016-12-05 | EDIT | Sale | 80,000 | 15.74 | 1,259,200 |
| 2016-11-23 | EDIT | Sale | 21,480 | 15.71 | 337,450 |
| 2016-11-22 | EDIT | Sale | 12,819 | 15.77 | 202,155 |
| 2016-11-16 | EDIT | Sale | 30,830 | 16.30 | 502,529 |
| 2016-11-14 | EDIT | Sale | 58,035 | 17.16 | 995,880 |
| 2016-11-15 | EDIT | Sale | 30,865 | 17.16 | 529,797 |
| 2016-09-08 | EDIT | Sale | 500,000 | 16.80 | 8,400,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Bitterman Kevin
(Officer of Disc Medicine, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.